Prof. Silvio Tatti MD, MSc, Phd, FACOG Past President IFCPC Hospital de Clínicas “José de San Martín” University of Buenos Aires Introduction and Update of the new IFCPC nomenclature Professor Silvio Tatti Past President IFCPC Presented at the 7th world congress of the IFCPC in Rome, Italy in 1990. Developed by a Nomenclature Committee headed by Adolf Stafl 4º IFCPC Nomenclature - 2011 Jim Bentley - Canada Jacob Bornstein - Israel Peter Bosze – Hungary Frank Girardi – Austria Hope Haefner - USA Patrick Walker – UK Silvio Tatti – Argentina IFCPC board Michael Menton – Germany Myriam Perrota – Argentina/ Walter Prendiville – Ireland Peter Russell - Australia Mario Sideri – Italy Bjorn Strander – Sweden Aureli Torne – Spain Transformation Zone Classification Type 1 Completely ectocervical Fully visible small or large Transformation Zone Classification Type 2 has endocervical component Fully visible may have ectocervial component which may be small or large Type 3 has endocervical component is not fully visible may have ectocervial component which may be small or large 2011 IFCPC colposcopic terminology - addendum Excision treatment types Why do we need a nomenclature of excision treatment types? To avoid using “conization”, “cone biopsy” “Big loop excision”, “small loop excision” To educate ourselves with the current understanding of how extensive an excision should be done 2011 IFCPC colposcopic terminology - addendum Excision treatment types Type 1 - resection of a type 1 TZ Type 2 – resection of a type 2 TZ Type 3 – resection of a type 3 TZ, glandular disease, suspected micro invasion or as a repeat treatment Courtesy of Dr Prendiville Courtesy of Dr Prendiville Why do we need a nomenclature of the size of the excised specimen? The dimensions of the excised specimen are significant to future pregnancy outcome: Systematic reviews documented an increase in pre-term delivery with an increase in the size of the excised specimen Studies sometimes used : “cone height”, “cone depth“, etc. Height Depth Length Thickness Circumference Excision treatment Excision type 1,2,3 types Excision specimen dimensions Length - the distance from the distal/external margin to the proximal/internal margin Thickness - the distance from the stromal margin to the surface of the excised specimen. Circumference (Optional)- the perimeter of the excised specimen Terminology : 3 fundamental principles 1.Communicate clinically relevant information from the laboratory to the patient’s health care provider. 2.Uniform and reasonably reproducible across different pathologists and laboratories and also flexible enough to be adapted in a wide variety of lab settings and geographic locations 3.Reflect the most current understanding of the disease process These principles were adopted by the LAST Project Robert J. Kurman, MD Forward to the Bethesda Atlas, 2nd edition What is LAST? A unified histopathological nomenclature Use a single set of diagnostic term It is recommended for all HPV-associated preinvasive squamous lesions of the lower anogenital tract (LAT). Reflects HPV biology and clinical management Infection & Precancer Biology & Management Biology & Management The difficulty of pathologists (H E) is to interpretate –IN2 lesions The interobserver agreement for CIN 2 is Benign Kappa 0.52 CIN1 Kappa 0.24 CIN2 Kappa 0.20 CIN3+ Kappa 0.61 Robertson et al. J Clin Pathol 1989;42:231-8. Distribution of 56 cases according to number of different diagnoses – by 22 pathologists From: Ceballos KM: Int J Gynecol Pathol, Volume 27(1).January 2008.101-107 Teresa Darragh MD Negative LSIL HSIL AIS Teresa Darragh MD An equivocation that is NOT reproducible A representation of incomplete sampling ~2/3s HSIL; ~1/3 LSIL A management safety net? Does not reflect our current understanding: infection vs. precancer A Distinct Biologic Stage? Ugly Looking CIN1? Not So Ugly CIN3? Teresa Darragh MD LSIL CIN 2 P16P16+ HSIL LAST terminology for the cervix, vulva and vagina WHO Blue Book - April 2014 HSIL vs MIMIC of HSIL p16 positive = HSIL Teresa Darragh MD WHO Blue Book - April 2014 HSIL vs REACTIVE p16 negative = Reactive Teresa Darragh MD Cervical Biopsy LAST Recommendations The morphology suggest HSIL vs mimic a precancer lesion The morphology suggest CIN 2 and we need to apply p16 to define if this is HSIL or LSIL To define a disagreement in between two patholgists. One think it is a –IN2 and the other –IN3 Do not recommend the use of p16 in a define –IN1, -IN or Cervical cancer Conclusions In the near future the implementation of preventive HPV vaccines in adolescents will produce changes in frequency of HPV lesions in this population and in screening methods (use of molecular tests). Special Circumstances The morphology suggests LGSIL, but the cytology results ASC-H, ACG or ASC-US/VPH+16 [email protected]
© Copyright 2026 Paperzz